SEO URLwww.firestrike.ai/deals/bluejay-therapeutics-mirum-acquisition-2026-2

acquisitionAnnounced · Jan 25, 2026Professional, Scientific, and Technical Services (541)Source · CredibleArticle · Factual

Bluejay Therapeutics · Mirum

Mirum acquires Bluejay Therapeutics

David Najork · Founding Software Engineer

Announced Jan 25, 2026 · Updated Apr 29, 2026 · 1 min read

ShareX LinkedIn Email

Deal value

$820M

Target

Bluejay Therapeutics

Acquirer

Mirum

Full Acquisition

Status

Pending

Mirum agreed to acquire Bluejay Therapeutics. Reported deal value: $820M. Status: Pending. Sector: Not specified. Target headquarters context: United States.

This page summarizes publicly available information about the transaction as of 2026-01-25. Figures and status may change as filings and press coverage update.

Mirum Pharmaceuticals , Inc. entered into a definitive agreement to acquire Bluejay Therapeutics , Inc. for $810 million on December 8, 2025

Deal timeline

Announced

Jan 25, 2026 · marketscreener.com

Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.

Sector context

This transaction is classified in Professional, Scientific, and Technical Services (541) with a reported deal value of $820M. Figures and status may change as sources update.

Sources: marketscreener.com · Primary article · FireStrike proprietary index